Bright Malika and Khadija Brightening Spot Treatment

Manufacturer
Pulsaderm, LLC
Effective date
2019-02-27
Label type
HUMAN OTC DRUG LABEL
Version
1
Source
legacy-cache
Hydrated at
2026-08-02 00:30:21

Label at a glance#

ProductBright Malika and Khadija Brightening Spot Treatment
Active ingredientHYDROQUINONE
Label structure7 sections

Indications and uses

Lightens dark spots in the skin such as freckles, age spots and liver spots.

Dosage and administration

Adults: Apply a thin layer on the affected areas twice daily, or as directed by physician. If no improvement is seen after three months of treatment, discontinue use of this product and consults physician. Lightening effect of this product may be less noticeable on very dark skin. Children under 12-years of age: Do not use this product unless directed by physician  Sun exposure should be limited by using sunscreen...

Label contents#

Full prescribing information#

ACTIVE INGREDIENT:

OTC - ACTIVE INGREDIENT SECTION

Hydroquinone 2.00%

OTC - PURPOSE SECTION

Skin Lightener

USES:

INDICATIONS & USAGE SECTION

Lightens dark spots in the skin such as freckles, age spots and liver spots.

WARNINGS:

WARNINGS SECTION

*For external use only.
*Avoid contact with eyes or eyelids.
*Some users of this product may experience mild skin irritation. Consult physician if skin irritation becomes severe.

Do not use on

OTC - DO NOT USE SECTION

children under 12, unless directed by physician.

KEEP OUT OF REACH OF CHILDREN.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

If swallowed, contact physician or poison control center immediately.

SPL UNCLASSIFIED SECTION

Store at room temperature.

DIRECTIONS:

DOSAGE & ADMINISTRATION SECTION

Adults: Apply a thin layer on the affected areas twice daily, or as directed by physician.

  • If no improvement is seen after three months of treatment, discontinue use of this product and consults physician.
  • Lightening effect of this product may be less noticeable on very dark skin.
  • Children under 12-years of age: Do not use this product unless directed by physician 
  • Sun exposure should be limited by using sunscreen agent, sun blocking agent, or protective clothing to cover bleached skin when using, and after using this product, in order to prevent darkening from reoccurring.

OTHER INGREDIENTS:

INACTIVE INGREDIENT SECTION

Algae Extract, Aloe Barbadensis Leaf (Aloe Vera Gel) Juice, Aqua (Deionized Water), Ascorbic Acid (Vitamin C), Bis-Vinyl Dimethicone/Dimethicone Copolymer, Butylene Glycol, C12-15 Alkyls Benzoate, Caprylic/Capric Triglyceride, 
Cyclopentasiloxane, Diazolidinyl Urea, Glucosamine HCI, Glycerin, Glycolic Acid, Glycyrrhiza Glabra (Licorice) Extract,
Hydroxyethylcellulose, lsohexadecane, Kojic Acid, Methyl Paraben, Morus Alba (Mulberry) Extract, Polysorbate 80, Propyl Paraben,
Propylene Glycol, Sodium Acryloyldimethyl Taurate Copolymer, Sodium Ascorbyl Phosphate (Vitamin C), Sodium Metabisulfite,
Sodium PCA, Tetrasodium EDTA, Tocopheryl Acetate (Vitamin E), Urea, Vitis Vinifera (Grape) Seed Extract, Yeast Extract.

Package Labeling:

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

LabelLabel

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 28 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
71177-00871177-008-15

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 27 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
dcf2abfb-7a6a-7503-e053-2a95a90ab32582e5e06e-ffdf-4d17-e053-2a91aa0a76882022-04-18WarningsExact identifier
spl set id: 82e5e06e-ffdf-4d17-e053-2a91aa0a7688

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.